1 / 15

Hypoxic Ischemic Encephalopathy

Hypoxic Ischemic Encephalopathy. Electrolyte and Acid-base Disturbances. Sodium Hypernatremia and hyponatremia Impaired arousal and cognition Seizures Myoclonus Tremor Hyponatremia May have focal deficits Correct for hyperglycemia and pseudohyponatremia (high triglycerides)

kamos
Download Presentation

Hypoxic Ischemic Encephalopathy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hypoxic Ischemic Encephalopathy

  2. Electrolyte and Acid-base Disturbances • Sodium • Hypernatremia and hyponatremia • Impaired arousal and cognition • Seizures • Myoclonus • Tremor • Hyponatremia • May have focal deficits • Correct for hyperglycemia and pseudohyponatremia (high triglycerides) • Rapid correction predisposes to osmotic demyelination syndrome (ODS) • Obtundation • Conjugate gaze palsy • Corticospinal tract signs • Pseudobulbar palsy • Potentially fatal • Hypernatremia • Rapid correction may cause cerebral edema (idiogenic osmoles)

  3. Osmotic Demyelination Syndrome

  4. Electrolyte and Acid-base Disturbances (cont.) • Calcium disorders • Impaired sensorium (agitation, delusions, hallucinations) • Seizures (more common with hypocalcemia) • Hypercalcemia • Hyperparathyroidism (usual cause) • Anorexia, vomiting, osmotic diuresis • Impaired neuromuscular transmission (generalized weakness and hyporeflexia) • Fluid resuscitation • Furosemide, calcitonin, corticosteroids, bisphosphonates, plicamycin, and hemodialysis as adjunctive therapy • Hypocalcemia • Tetany and extrapyradamidal signs when severe • Magnesium • Calcium channel blockade • Symptoms uncommon • Hypermagnesemia (typically during IV infusion for eclampsia) • Impaired arousal, hypotension, decreased neuromuscular transmission, respiratory depression • Hypomagnesemia • Coexists and similar to hypocalcemia • Hypophosphatemia • Rarely symptomatic (when severe—depressed consciousness and seizures)

  5. Electrolyte and Acid-base Disturbances (cont.) • Respiratory acidosis • CO2 narcosis • Hypoxemia and hypotension • Respiratory alkalosis • Transient confusion and lightheadedness • Perioral and acralparesthesias (decreased ionized calcium) • Metabolic acid-base disorders • Acute encephalopathy typically due to the underlying metabolic abnormality rather than the acid-base disturbance

  6. End Organ Failure • Hepatic encephalopathy • Acetaminophen, viral hepatitis, and toxin-mediated injury can cause acute hepatic failure • GI bleeding, high protein intake, meds, infections may trigger encephalopathy with chronic liver disease • Clinical findings • Depressed consciousness, agitation, asterixis, posturing, extensor plantar reflexes • EEG shows triphasic waves • Ammonia elevated in 90% • Pathophysiology • Decreased clearance of metabolic toxins and meds • Blood-brain barrier permeability (cerebral edema) • Treatment • Lactulose, rifaximin, transplantation

  7. End Organ Failure (cont.) • Uremic encephalopathy • Clinical manifestations • Confusion >> coma • Myoclonus, asterixis • EEG may show triphasic waves • Pathophysiology • Decreased clearance of neurotoxins • Treatment • Renal replacement therapy • Dialysis dysequilibrium • During or after dialysis in those recently started on dialysis • Headache, seizures, lethargy, elevated intracranial pressure • Treatment • Stop/slow dialysis • Osmotherapy may be required

  8. Generalized Slowing and Triphasic Waves on EEG

  9. Nutritional • Thiamine deficiency • Wernicke encephalopathy • Affects mammillary bodies, medial dorsal thalamus, and periaqueductal gray • Triad (mental status changes, ataxia and opthalmoplegia) seldom all present • Occasionally postural hypotension, cardiac failure, and GI symptoms • Treatment • IV thiamine • Korsakoff syndrome • Chronic disorder (often transition from Wernicke encephalopathy) • Impaired memory and learning out of proportion to other cognitive domains • Profound anterograde and retrograde amnesia • Confabulation, anxiety, apathy • Infrequent recovery

  10. Nutritional (cont.) • Niacin deficiency • Pellagra (pelleagra “rough skin”) • Seen in ETOH use disorder, anorexia nervosa, INH use • Irritability, insomnia, confusion, and cognitive impairment • Startle myoclonus • Photosensitive dermatitis, diarrhea • Nicotinic acid metabolites in urine • Treatment • IV niacin 25-250 mg 2-3 times daily • Lead toxicity • Altered mental status, neuropathy (rare in isolation), dementia • Intractable colic, weakness including wrist/foot drop, thin blue-gray line at gums (Burton line) • Microcytic, hypochromic anemia with basophilic stippling or RBCs • Arsenic toxicity • Painful neuropathy • Hair and nail changes (Mees lines) • Liver and renal dysfunction • Mercury toxicity • Color vision changes, neuropathy • Pulmonary and renal dysfunction • Bismuth toxicity • Apathy, ataxia, headaches, myoclonus, hallucinations and seizures • Manganese toxicity • Parkinsonism, gait abnormalities, tremor, and psychiatric disturbances • Can occur with TPN containing trace elements

  11. Endocrine Disorders • Thyrotoxicosis (Graves’ disease or toxic multinodular goiter) • Precipitating factors • Trauma, obstetric labor, lithium, iodinated contrast, non-thyroid surgery • Agitation, restlessness, emotional lability, confusion, psychosis, coma • Tachycardia, fever • Hypercoagulability (high index of suspicion for cerebral venous sinus thrombosis) • Elevated thyroid levels, decreased TSH, high calcium, mild leukocytosis, hyperglycemia, elevated serum LDH and aminotransferase • Treatment • PTU or methimazole followed by iodine • Supportive management with propranolol, antipyretics, and fluids • 75% mortality with thyrotoxic storm • Myxedema coma (rare, mortality 70%) • Precipitating factors • Infection, heart failure, trauma, cold exposure, anesthesia, and medication non-adherence superimposed on underlying hypothyroidism • Cognitive dysfunction, depression, lethargy, somnolence, coma, hallucinations (“myxedema madness”), seizures • Hypoventilation, bradycardia, cardiomegaly, decreased contractility • Hyponatremia, decreased GFR • Hypothermia • Dry skin, sparse hair, macroglossia • Periorbital, foot, and hand edema • Decreased thyroid levels, elevated TSH (no correlation with severity), elevated CK, normocytic anemia, elevated CSF protein and opening pressure • Treatment • Thyroid hormone replacement and supportive

  12. Endocrine Disorders (cont.) • Hashimoto encephalopathy (controversial) • “Steroid responsive encephalopathy with autoimmune thyroiditis” (SREAT) and “non-vasculitic autoimmune meningoencephalitis” (NAIM) • Common—Clouding of consciousnes with reduced wakefulness, attention, or cognitive function • Reported—stroke-like episodes, coma, seizures, subacute cognitive decline, tremor, myoclonus, transient aphasia, sleep abnormalities, gait dysfunction, hallucinations • High titers of antithyroid antibodies (ATG, TPO, antithyroid microsomal) • MRI may show leukoencephalopathy • Often prompt response to IVMP 1 gm daily 3-5 days followed by prednisone 60-100 mg daily up to 30 days • Acute adrenal insufficiency • Causes • Primary injury to adrenal gland • Secondary—interference with ACTH release by the pituitary gland • Tertiary—interference with corticotropin releasing hormone by the hypothalamus • Iatrogenic—suppression of HPA axis due to chronic corticosteroid use • Relative—inappropriately low cortisol production and adrenal suppression associated with sepsis (incidence 20-60%) • Manifestations • Confusion, lethargy, coma, convulsions • Circulatory failure, abdominal pain, vomiting, fever, hypoglycemia, hyperkalemia, hyponatremia • Treatment • Circulatory support • Stress-dose steroids

  13. Autoimmune Encephalitis

  14. Autoimmune Encephalitis

  15. Initial Management and Assessment • ABCs • Consider the following lab studies: • Serum glucose and electrolytes • Complete blood count, lactate, procalcitonin • Liver and kidney function studies • Urine toxicology screen • Arterial blood gas • Carboxyhemoglobin level (if carbon monoxide exposure suspected) • For coma of acute onset and unknown cause administer: • Dextrose, 25 g IV (to treat possible hypoglycemia) • Thiamine, 100 mg IV (to prevent or treat Wernicke encephalopathy) • Naloxone, 1 mg IV (to treat possible opiate overdose) • Treat ongoing seizures • Brain imaging (CT or MRI) if focal intracranial lesion is suspected • CSF analysis if meningitis or SAH is suspected

More Related